Download PDF
CC BY-NC-ND 4.0 · Endosc Int Open 2019; 07(02): E186-E188
DOI: 10.1055/a-0764-4736
Case report
Owner and Copyright © Georg Thieme Verlag KG 2019

Alcohol-free EUS-guided chemoablation of multiple pancreatic insulinomas

Daniel Gaballa
1   Department of Internal Medicine, Division of Gastroenterology, Penn State University Hospital, Hershey Medical Center, Hershey, Pennsylvania, United States
,
Catherine S. Abendroth
2   Department of Pathology, Division of Anatomic Pathology, Penn State University Hospital, Hershey Medical Center, Hershey, Pennsylvania, United States
,
Matthew T. Moyer
1   Department of Internal Medicine, Division of Gastroenterology, Penn State University Hospital, Hershey Medical Center, Hershey, Pennsylvania, United States
› Author Affiliations
Further Information

Publication History

submitted13 February 2018

accepted after revision25 June 2018

Publication Date:
18 January 2019 (online)

Also available at
   Permissions and Reprints

Abstract

Background and study aims Endoscopic ultrasound (EUS)-guided chemoablation with ethanol lavage, followed by infusion with paclitaxel, has been found to be effective for treatment of mucinous pancreatic cysts. However, there are notable adverse events (AEs) associated with ethanol and its undesirable inflammatory effects on local tissue and vessels. The recent ChARM trial demonstrated that removing ethanol from the cyst ablation process resulted in equivalent efficacy while significantly reducing associated AEs. Encouraged by these results, we speculated that alcohol-free chemoablation can be applied to treatment of solid tumors, as described in our case with a patient with severe and symptomatic recurrent hypoglycemia in the setting of multifocal insulinomas. As a result, the patient saw a significant reduction in symptoms. EUS-guided alcohol-free chemoablation may represent a new alternative to previously established therapies that will ultimately reduce risk of AEs.

 

  • References

  • 1 Lawrence B, Gustafsson BI, Chan A. et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am 2011; 40: 1
    CrossrefPubMedGoogle Scholar
  • 2 Hirshberg B, Cochran C, Skarulis M. et al. Malignant insulinoma. Cancer 2005; 104: 264-272
    CrossrefPubMedGoogle Scholar
  • 3 Mathur A. The Surgical clinics of North America: Insulinoma. WB Saunders Company; 2009 89. 1105
    PubMedGoogle Scholar
  • 4 Moyer MT, Sharzehi S, Abraham M. et al. The safety and efficacy of an alcohol-free pancreatic cyst ablation protocol. Gastroenterology 2017; 153: 1295-1303
    CrossrefPubMedGoogle Scholar
  • 5 Moyer MT, Dye CE, Sharzehi S. et al. Is alcohol required for effective pancreatic cyst ablation? The prospective randomized CHARM trial pilot study. Endosc Intl Open 2016; 4: E603-E607
    PubMedGoogle Scholar
  • 6 Levy MJ, Thompson GB, Topazian MD. et al. US-guided ethanol ablation of insulinomas: a new treatment option. Gastrointest Endosc 2012; 75: 200-206
    CrossrefPubMedGoogle Scholar
  • 7 Deprez PH, Claessens A, Borbath I. et al. Successful endoscopic ultrasound-guided ethanol ablation of a sporadic insulinoma. Acta Gastroenterol Belg 2008; 71: 333-337
    PubMedGoogle Scholar
  • 8 DeWitt J, McGreevy K, Schmidt CM. et al. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc 2009; 70: 710-723
    CrossrefPubMedGoogle Scholar
  • 9 Oh HC, Seo DW, Lee TY. et al. New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest Endosc 2008; 67: 636-642
    CrossrefPubMedGoogle Scholar